Literature DB >> 19807734

Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis.

Y Wang1, S Ito, Y Chino, D Goto, I Matsumoto, H Murata, A Tsutsumi, T Hayashi, K Uchida, J Usui, K Yamagata, T Sumida.   

Abstract

To determine the cytokine balance in patients with lupus nephritis (LN), we analysed kidney-infiltrating T cells. Renal biopsy samples from 15 systemic lupus erythematosus (SLE) patients were used. In accordance with the classification of International Society of Nephrology/Renal Pathology Society, they were categorized into Class III, Class III+V (Class III-predominant group, n = 4), Class IV, Class IV+V (Class IV-predominant group, n = 7) and Class V (n = 4) groups. The single-cell samples of both the glomelular and interstitial infiltrating cells were captured by laser-microdissection. The glomerular and interstitial infiltrating T cells produced interleukin (IL)-2, IL-4, IL-10, IL-13 and IL-17 cytokines in the Class III-predominant, Class IV-predominant and Class V groups. Interferon-gamma was detected only in the glomeruli of the Class III-predominant and Class V group samples. The expression level of IL-17 was correlated closely with clinical parameters such as haematuria, blood urea nitrogen level, SLE Disease Activity Index scores in both glomeruli and interstitium, urine protein level in glomeruli and serum creatinine and creatinine clearance levels in interstitium. This suggests that the glomerular infiltrating T cells might act as T helper type 1 (Th1), Th2 and Th17 cells while the interstitial infiltrating T cells, act as Th2 and Th17 cells in the Class III-predominant and Class V groups. In contrast, both the glomerular and interstitial infiltrating T cells might act as Th2 and Th17 cells in the Class IV-predominant group. The cytokine balances may be dependent upon the classification of renal pathology, and IL-17 might play a critical role in SLE development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19807734      PMCID: PMC2802690          DOI: 10.1111/j.1365-2249.2009.04031.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

Review 1.  Challenges of single-cell diagnostics: analysis of gene expression.

Authors:  Randy Todd; David H Margolin
Journal:  Trends Mol Med       Date:  2002-06       Impact factor: 11.951

2.  Gene-expression analysis of single cells-nested polymerase chain reaction after laser microdissection.

Authors:  Xin Shi; Jörg Kleeff; Zhao-Wen Zhu; Bruno Schmied; Wen-Hao Tang; Arthur Zimmermann; Markus W Buchler; Helmut Friess
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

3.  The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findings.

Authors:  S Morimoto; Y Tokano; H Kaneko; K Nozawa; H Amano; H Hashimoto
Journal:  Autoimmunity       Date:  2001       Impact factor: 2.815

4.  Predominance of Th1 immune response in diffuse proliferative lupus nephritis.

Authors:  K Masutani; M Akahoshi; K Tsuruya; M Tokumoto; T Ninomiya; T Kohsaka; K Fukuda; H Kanai; H Nakashima; T Otsuka; H Hirakata
Journal:  Arthritis Rheum       Date:  2001-09

Review 5.  The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.

Authors:  P Matthys; K Vermeire; H Heremans; A Billiau
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

6.  Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus.

Authors:  C K Wong; C Y Ho; E K Li; C W Lam
Journal:  Lupus       Date:  2000       Impact factor: 2.911

7.  T cell receptor repertoire of T cells in the kidneys of patients with lupus nephritis.

Authors:  Hideyuki Murata; Ryutaro Matsumura; Akio Koyama; Takao Sugiyama; Makoto Sueishi; Kazuko Shibuya; Akito Tsutsumi; Takayuki Sumida
Journal:  Arthritis Rheum       Date:  2002-08

8.  Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile.

Authors:  A Spadaro; T Rinaldi; V Riccieri; E Taccari; G Valesini
Journal:  Clin Exp Rheumatol       Date:  2002 Mar-Apr       Impact factor: 4.473

9.  A novel evaluation method for paraffinized human renal biopsies using quantitative analysis of microdissected glomeruli and VCAM-1 as marker of inflammatory mesangial cell activation.

Authors:  Jochen W U Fries; Tanja Roth; Hans-Peter Dienes; Manfred Weber; Margarete Odenthal
Journal:  Nephrol Dial Transplant       Date:  2003-04       Impact factor: 5.992

10.  Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis.

Authors:  Monika Hofbauer; Solveigh Wiesener; Holger Babbe; Axel Roers; Hartmut Wekerle; Klaus Dornmair; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-21       Impact factor: 11.205

View more
  51 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Prenatal TCDD in mice increases adult autoimmunity.

Authors:  Steven D Holladay; Amjad Mustafa; Robert M Gogal
Journal:  Reprod Toxicol       Date:  2010-08-20       Impact factor: 3.143

3.  P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.

Authors:  Jijun Zhao; Hongyue Wang; Chao Dai; Hongyang Wang; Hui Zhang; Yuefang Huang; Shuang Wang; Felicia Gaskin; Niansheng Yang; Shu Man Fu
Journal:  Arthritis Rheum       Date:  2013-12

Review 4.  Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.

Authors:  Min S Shin; Naeun Lee; Insoo Kang
Journal:  Curr Opin Rheumatol       Date:  2011-09       Impact factor: 5.006

5.  Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.

Authors:  S A Summers; D Odobasic; M B Khouri; O M Steinmetz; Y Yang; S R Holdsworth; A R Kitching
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 6.  Emerging cell and cytokine targets in rheumatoid arthritis.

Authors:  Gerd R Burmester; Eugen Feist; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2013-11-12       Impact factor: 20.543

Review 7.  IL-17 in systemic lupus erythematosus.

Authors:  José C Crispín; George C Tsokos
Journal:  J Biomed Biotechnol       Date:  2010-04-06

8.  Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.

Authors:  Kamini Shah; Won-Woo Lee; Seung-Hyun Lee; Sang Hyun Kim; Seong Wook Kang; Joe Craft; Insoo Kang
Journal:  Arthritis Res Ther       Date:  2010-03-24       Impact factor: 5.156

Review 9.  Cytokine overproduction, T-cell activation, and defective T-regulatory functions promote nephritis in systemic lupus erythematosus.

Authors:  Marco Tucci; Stefania Stucci; Sabino Strippoli; Francesco Silvestris
Journal:  J Biomed Biotechnol       Date:  2010-06-29

10.  Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus.

Authors:  Sebastian Dolff; Daniel Quandt; Benjamin Wilde; Thorsten Feldkamp; Fan Hua; Xin Cai; Christof Specker; Andreas Kribben; Cees G M Kallenberg; Oliver Witzke
Journal:  Arthritis Res Ther       Date:  2010-07-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.